Premier Alternatives

Debut Biotechnology

San Diego, CA · Founded 2019 · Privately Held (backing)

Developer of a biotechnology platform designed to create climate-positive products. Debut Biotechnology is based in San Diego, CA and was founded in 2019. It was valued at $222 million at its early-stage round in Oct 2023, the last priced event on record. It has raised $89.3 million across 4 recorded rounds; the latest was a $4 million seed round in Nov 2021.

PMV mark · valuation
$222.0M
Oct 2026
Priced at
its early-stage round
Oct 2023
Total raised
$89.3M
Last round
Seed Round
Nov 2021

Debut Biotechnology key facts

as of Oct 2026
  • Developer of a biotechnology platform designed to create climate-positive products.
  • Debut Biotechnology is valued at approximately $222.0M as of Oct 2026, set at its early-stage round, Oct 2023; nothing has traded since, per PrivateMarketView’s mark.
  • It has raised $89.3M across 4 recorded rounds; the latest was Seed Round ($4.0M) in Nov 2021.
  • Notable investors include F-Prime Capital, EDBI, GS Futures, Cavallo Ventures, Sandbox Industries — 23 tracked in total.
  • Debut Biotechnology has filed 4 Form Ds with the SEC since 2020, most recently Nov 2021 ($4.0M sold to 2 investors).
  • Status: Privately Held (backing).
PrivateMarketView mark
LOW confidence
$222.0M

Valued at $222.0M at its early-stage round, Oct 2023. Nothing has traded since.

set by its last priced roundas of Oct 2026question about this number?
Free account
More of Debut Biotechnology with a free account
  • ·The complete investor list: 23 names
  • ·Watch Debut Biotechnology: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Debut Biotechnology funding rounds

4 rounds
Nov 2021Seed Round$4.0MSEC filing▮
Jul 2021Early Stage VC$22.6MSEC filing▮
Sep 2020Seed Round$2.2MSEC filing▮
Dec 2019Seed Round$2.6MSEC filing▮
Full funding history →

Debut Biotechnology valuation

Debut Biotechnology was valued at $222 million at its early-stage round in Oct 2023. That is the last priced event on record: no secondary trade or institutional fund mark has moved the figure since.

How much has Debut Biotechnology raised?

Debut Biotechnology has raised $89.3 million in total; 4 of its rounds are on record, from 2019 on. The largest on record was a $4 million seed round in Nov 2021.

Debut Biotechnology has filed 4 Form Ds with the SEC since 2020, most recently in Nov 2021 ($4 million sold to 2 investors).

Debut Biotechnology investors

23 investors are on record for Debut Biotechnology, including F-Prime Capital, EDBI, GS Futures and Cavallo Ventures. By type, the record holds 5 venture capital firms and 1 family office. The seed round in Nov 2021 drew 2 investors.

About Debut Biotechnology

Developer of a biotechnology platform designed to create climate-positive products. The company offers features such as research and development capabilities focused on sustainable practices, partnerships with organizations to promote ecological balance, and a commitment to creating environmentally friendly alternatives, fostering product performance rooted in science, enabling businesses to reduce their carbon footprint while contributing positively to environmental and social well-being.

Sector
Healthcare
HQ
San Diego, CA, United States
Founded
2019
Employees
87
Ownership
Privately Held (backing)

Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.